Literature DB >> 31367062

Microbiome therapeutics go small molecule.

Megan Cully.   

Abstract

Keywords:  Therapeutics

Year:  2019        PMID： 31367062     DOI： 10.1038/d41573-019-00122-8

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  15 in total

Review 1.  New Topical Therapies in Development for Atopic Dermatitis.

Authors:  Egídio Freitas; Melinda Gooderham; Tiago Torres
Journal:  Drugs       Date:  2022-05-21       Impact factor: 9.546

Review 2.  The promise of the gut microbiome as part of individualized treatment strategies.

Authors:  Daniel A Schupack; Ruben A T Mars; Dayne H Voelker; Jithma P Abeykoon; Purna C Kashyap
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

Review 3.  Molecular tools for probing the microbiome.

Authors:  Marcelo Der Torossian Torres; Cesar de la Fuente-Nunez
Journal:  Curr Opin Struct Biol       Date:  2022-08-16       Impact factor: 7.786

Review 4.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

Review 5.  The Gut Microbiome and Bone Strength.

Authors:  Macy Castaneda; Jasmin M Strong; Denise A Alabi; Christopher J Hernandez
Journal:  Curr Osteoporos Rep       Date:  2020-10-08       Impact factor: 5.096

Review 6.  Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms.

Authors:  David J Lynn; Saoirse C Benson; Miriam A Lynn; Bali Pulendran
Journal:  Nat Rev Immunol       Date:  2021-05-17       Impact factor: 108.555

Review 7.  The Microbiome and the Gut-Liver-Brain Axis for Central Nervous System Clinical Pharmacology: Challenges in Specifying and Integrating In Vitro and In Silico Models.

Authors:  Kyle G Hawkins; Caleb Casolaro; Jacquelyn A Brown; David A Edwards; John P Wikswo
Journal:  Clin Pharmacol Ther       Date:  2020-05-29       Impact factor: 6.875

8.  Special issue on the human microbiome: from symbiosis to therapy.

Authors:  Amit Sharma; Sin-Hyeog Im
Journal:  Exp Mol Med       Date:  2020-09-10       Impact factor: 8.718

9.  The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.

Authors:  Stephen J Blake; Jane James; Feargal J Ryan; Jose Caparros-Martin; Georgina L Eden; Yee C Tee; John R Salamon; Saoirse C Benson; Damon J Tumes; Anastasia Sribnaia; Natalie E Stevens; John W Finnie; Hiroki Kobayashi; Deborah L White; Steve L Wesselingh; Fergal O'Gara; Miriam A Lynn; David J Lynn
Journal:  Cell Rep Med       Date:  2021-12-08

Review 10.  Microbial metabolites: cause or consequence in gastrointestinal disease?

Authors:  Serge Alain Fobofou; Tor Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-10       Impact factor: 4.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.